|

Sorbitol Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Indications

  • Gastric Junction Adenocarcinoma1
  • Neoadjuvant Therapies1
  • Immunotherapy1
  • Gastric Cancer1
  • Cancer1

Other1 trial

Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.